HOUT-17. ELDERLY PATIENTS >65YEARS OF AGE WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME GAIN LIFE TIME FROM TREATMENT WITH TUMOR TREATING FIELDS AND TEMOZOLOMIDE
2015 ◽
Vol 124
(2)
◽
pp. 265-273
◽
2018 ◽
Vol 101
(2)
◽
pp. e6
2015 ◽
Vol 33
(15_suppl)
◽
pp. e13046-e13046
2015 ◽
Vol 93
(3)
◽
pp. E59
2018 ◽
Vol 102
(3)
◽
pp. e223
Keyword(s):